» Articles » PMID: 8985251

P- and E-selectin Mediate Recruitment of T-helper-1 but Not T-helper-2 Cells into Inflammed Tissues

Overview
Journal Nature
Specialty Science
Date 1997 Jan 2
PMID 8985251
Citations 192
Authors
Affiliations
Soon will be listed here.
Abstract

When activated, T helper cells differentiate into one of two subsets, Th1 and Th2, characterized by distinct profiles of cytokine production. Th1 cells activate pro-inflammatory effector mechanisms involved in protection and autoimmunity, whereas Th2 cells induce humoral and allergic responses and downregulate local inflammation. Apart from differences in the repertoire of cytokines, no phenotypic attributes are established that distinguish the two subsets. Here we show that Th1 cells, but not Th2 cells, are able to bind to P-selectin and E-selectin. Moreover, only Th1 cells can efficiently enter inflamed sites in Th1-dominated models, such as sensitized skin or arthritic joints, but not in a Th2-dominated allergic response. Immigration of Th1 cells into inflamed skin can be blocked by antibodies against P- and E-selectin. These results provide evidence for adhesion mechanisms to distinguish between the two T helper subsets and mediate their differential trafficking. They indicate that selective recruitment is an additional level of regulation for both effector function profile and character of a local immune response.

Citing Articles

Unraveling Ferroptosis: A New Frontier in Combating Renal Fibrosis and CKD Progression.

Jin R, Dai Y, Wang Z, Hu Q, Zhang C, Gao H Biology (Basel). 2025; 14(1).

PMID: 39857243 PMC: 11763183. DOI: 10.3390/biology14010012.


T Cell Surveillance during Cutaneous Viral Infections.

Pei L, Hickman H Viruses. 2024; 16(5).

PMID: 38793562 PMC: 11126121. DOI: 10.3390/v16050679.


Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review).

Wang Z, Deng Z, Dai F, Yuan M, Liu S, Li B Exp Ther Med. 2024; 27(4):166.

PMID: 38476909 PMC: 10928974. DOI: 10.3892/etm.2024.12453.


Actives from the Micro-Immunotherapy Medicine 2LMIREG Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function.

Jacques C, Marchand F, Chatelais M, Floris I J Inflamm Res. 2024; 17:1161-1181.

PMID: 38406323 PMC: 10894519. DOI: 10.2147/JIR.S445053.


Lymphocyte and CD62E expression in lichen planus and lichenoid reaction.

Werneck J, Goncalves L, Marques L, Junior A BMC Oral Health. 2022; 22(1):507.

PMID: 36397025 PMC: 9670570. DOI: 10.1186/s12903-022-02496-5.